Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer

Clinical trial NCT04919382 · RECRUITING

Trial details

NCT number: NCT04919382
Sponsor: Dwight Owen
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Extensive Stage Lung Small Cell Carcinoma Metastatic Lung Small Cell Carcinoma Recurrent Lung Small Cell Carcinoma Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8

Start date: 2022-01-26
Primary completion: 2027-12-30
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.